ATE424844T1 - Kombinationsvakzine für geflügel - Google Patents

Kombinationsvakzine für geflügel

Info

Publication number: ATE424844T1
Authority: AT; Austria
Prior art keywords: combination vaccine; poultry; ornithobacterium rhinotracheale; attenuated; live
Prior art date: 2003-12-23

Application number

AT04804958T

Other languages

English (en)

Inventor

Antonius Arnoldus Chris Jacobs

Empel Paul Cornelius Maria Van

Petrus Johannes Maria Nuijten

Original Assignee

Intervet Int Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-23

Filing date

2004-12-21

Publication date

2009-03-15

2004-12-21 Application filed by Intervet Int Bv filed Critical Intervet Int Bv

2009-03-15 Application granted granted Critical

2009-03-15 Publication of ATE424844T1 publication Critical patent/ATE424844T1/de

Links

229940001442 combination vaccine Drugs 0.000 title abstract 4
244000144977 poultry Species 0.000 title abstract 4
241001135620 Ornithobacterium rhinotracheale Species 0.000 abstract 3
230000002238 attenuated effect Effects 0.000 abstract 2
241000700605 Viruses Species 0.000 abstract 1
238000002649 immunization Methods 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
238000002255 vaccination Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Mycology (AREA)
Virology (AREA)
Microbiology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT04804958T 2003-12-23 2004-12-21 Kombinationsvakzine für geflügel ATE424844T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03104954		2003-12-23

Publications (1)

Publication Number	Publication Date
ATE424844T1 true ATE424844T1 (de)	2009-03-15

Family

ID=34717250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04804958T ATE424844T1 (de)	2003-12-23	2004-12-21	Kombinationsvakzine für geflügel

Country Status (9)

Country	Link
US (1)	US7785570B2 (de)
EP (1)	EP1699483B1 (de)
JP (1)	JP5063116B2 (de)
AT (1)	ATE424844T1 (de)
BR (1)	BRPI0417880A (de)
CA (1)	CA2550923A1 (de)
DE (1)	DE602004019971D1 (de)
ES (1)	ES2322272T3 (de)
WO (1)	WO2005063284A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6017993B2 (ja) *	2013-02-26	2016-11-02	京セラ株式会社	電力管理装置、通信制御装置、電力管理システム及び電力管理方法
KR20210068602A (ko)	2016-06-02	2021-06-09	조에티스 서비시즈 엘엘씨	감염성 기관지염에 대한 백신
WO2020096994A1 (en) *	2018-11-05	2020-05-14	University Of Florida Research Foundation, Inc.	Live self-destructing bacterial adjuvants to enhance induction of immunity
BE1028701B1 (nl) *	2020-10-13	2022-05-16	Poulpharm Bvba	Werkwijze voor autovaccin productie en verkregen autovaccin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA937652B (en)	1992-10-14	1994-05-04	Akzo Nv	New bacterium causing poultry disease and vaccine derived thereof
ATE196773T1 (de) *	1993-07-30	2000-10-15	Akzo Nobel Nv	Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
CA2181862C (en) *	1995-08-01	2009-12-22	Carla Christina Schrier	Mild newcastle disease virus vaccine
US20030149255A1 (en) *	2002-05-28	2003-08-07	Vanessa Lopes	Bird diagnostics and treatments

2004
- 2004-12-21 ES ES04804958T patent/ES2322272T3/es not_active Expired - Lifetime
- 2004-12-21 JP JP2006546172A patent/JP5063116B2/ja not_active Expired - Fee Related
- 2004-12-21 DE DE602004019971T patent/DE602004019971D1/de not_active Expired - Lifetime
- 2004-12-21 CA CA002550923A patent/CA2550923A1/en not_active Abandoned
- 2004-12-21 EP EP04804958A patent/EP1699483B1/de not_active Expired - Lifetime
- 2004-12-21 WO PCT/EP2004/053623 patent/WO2005063284A1/en not_active Ceased
- 2004-12-21 AT AT04804958T patent/ATE424844T1/de not_active IP Right Cessation
- 2004-12-21 BR BRPI0417880-7A patent/BRPI0417880A/pt not_active Application Discontinuation
- 2004-12-21 US US10/582,315 patent/US7785570B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2550923A1 (en)	2005-07-14
JP5063116B2 (ja)	2012-10-31
US20090053262A1 (en)	2009-02-26
ES2322272T3 (es)	2009-06-18
DE602004019971D1 (de)	2009-04-23
EP1699483B1 (de)	2009-03-11
JP2007518717A (ja)	2007-07-12
EP1699483A1 (de)	2006-09-13
WO2005063284A1 (en)	2005-07-14
US7785570B2 (en)	2010-08-31
BRPI0417880A (pt)	2007-04-27

Legal Events

Date	Code	Title	Description
2009-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
TW200806316A (en)	2008-02-01	Yeast-based vaccine for inducing an immune response
UA99659C2 (uk)	2012-09-10	Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
EA201070794A1 (ru)	2011-02-28	Рекомбинантные антигены rsv
ATE426412T1 (de)	2009-04-15	Adjuvante influenza-vakzine
TNSN07387A1 (en)	2009-03-17	C.perfringens alpha toxoid vaccine
CY1117673T1 (el)	2017-05-17	Ανασυνδυασμενα αντιγονα rsv
MX2009006178A (es)	2009-07-22	Vacuna contra salmonela.
ATE451119T1 (de)	2009-12-15	Untereinheit-impfstoff gegen das respiratorische synzytialvirus
MX375202B (es)	2025-03-06	Composiciones adyuvantes novedosas.
TN2011000182A1 (en)	2012-12-17	Live, attentuated respiratory syncytial virus
ZA200705087B (en)	2008-08-27	Pasteurella multocida vaccine
NZ585777A (en)	2012-09-28	Compositions and methods of enhancing immune responses to eimeria
CA2763359C (en)	2021-07-27	New human rotavirus strains and vaccines
GB2386072A (en)	2003-09-10	Novel vaccine
BRPI0508064A (pt)	2007-07-17	flavivìrus, composição de vacina e molécula de ácido nucléico
MX2012003827A (es)	2012-08-03	Toxina rtx citolitica de gallibacterium anatis.
DE60336927D1 (de)	2011-06-09
CY1116135T1 (el)	2017-02-08	Εμβολιο ροταϊου που διεγειρει ετεροτυπικη εγκαρσια προστασια
WO2011112906A3 (en)	2012-02-16	Novel immunogens and methods for discovery and screening thereof
ATE424844T1 (de)	2009-03-15	Kombinationsvakzine für geflügel
EA200301151A1 (ru)	2004-10-28	Вакцина против натуральной оспы
MX2021000949A (es)	2021-06-23	Nueva cepa de virus atenuada y su uso como una vacuna.
WO2008133645A3 (en)	2009-03-12	Combination vaccine for prevention of tularemia
MY158116A (en)	2016-08-30	Combination vaccine against streptococcus
ATE359815T1 (de)	2007-05-15	Streptococcus-phocae-vakzine